Sign in

CIK 0001590560

  • Large accelerated filer

uniQure N.V.

Sign in to watch
Ticker
QURE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
Phone
+1 339-970-7000
Business address
PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
Former names
uniQure B.V.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$192,950
in 1 filing, $193K under 10b5-1 plans

Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Meek David D. −$193K Director sold 23% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-25 Kapusta Matthew C CEO, Managing Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −28,716 45,862
2026-06-24 Kapusta Matthew C CEO, Managing Director Exercise or conversion 10b5-1 +4,128 $31.71 $131K 525,923
2026-06-24 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −6,696 $50.00 $335K 519,227
2026-06-24 Kapusta Matthew C CEO, Managing Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −4,128 74,578
2026-06-18 Kapusta Matthew C CEO, Managing Director Exercise or conversion 10b5-1 +4,656 $31.71 $148K 563,466
2026-06-18 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −4,656 $50.00 $233K 558,810
2026-06-18 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −37,015 $50.00 $1.9M 521,795
2026-06-18 Kapusta Matthew C CEO, Managing Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −4,656 78,706
2026-06-17 Kapusta Matthew C CEO, Managing Director Exercise or conversion 10b5-1 +62,581 $19.39 $1.2M 723,239
2026-06-17 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −23,977 $42.61 $1.0M 699,262
2026-06-17 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −6,023 $43.70 $263K 693,239
2026-06-17 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −32,581 $45.02 $1.5M 660,658
2026-06-17 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −56,929 $43.43 $2.5M 603,729
2026-06-17 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −33,334 $45.01 $1.5M 570,395
2026-06-17 Kapusta Matthew C CEO, Managing Director Sale 10b5-1 −11,585 $48.65 $564K 558,810
2026-06-17 Kapusta Matthew C CEO, Managing Director Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −62,581 21,082
2026-06-17 Balachandran Madhavan Director Exercise or conversion 10b5-1 +5,295 $31.71 $168K 48,549
2026-06-17 Balachandran Madhavan Director Exercise or conversion 10b5-1 +6,390 $19.39 $124K 54,939
2026-06-17 Balachandran Madhavan Director Sale 10b5-1 −5,295 $47.08 $249K 49,644
2026-06-17 Balachandran Madhavan Director Sale 10b5-1 −4,700 $43.66 $205K 44,944

Page 2 of 13 · 251 trades